Alexey Konov
RBV CAPITAL
About speaker
Alexey Konov
MSU (1989); Ph.D., molecular biology, University Louis Pasteur, France (1998)
20 years of overall experience in management and life sciences, including 8 years of venture investment experience ("Bioprocess Capital Ventures")
Board member in Retrosense Therapeutics, LLC (acquired by NYSE:AGN)
Sessions participant
The Golden Mean. The balance of the state and private capital as a key factor for the the venture business development
16 October 17:30, PUSHCHINO HALL